2023 FDA Broad Agency Announcement Day Agenda
2023 FDA BAA Day
October 25, 2023, 1:00 p.m. - 4:30 p.m. EST
Recording
Recording of the full event (3 hours, 34 minutes), including closed captioning and an audio transcript. Available slides are posted on the event page.
Agenda
All times are Eastern Standard Time. Please see the event page for additional information.
Time | Agenda item | Presenter |
1:00 p.m. |
Welcome and Opening Remarks
|
Ms. Shaila Shaheed, Supervisory Program Manager, ORSI Ms. Vidya Vish, Supervisory Contract Specialist, OAGS |
1:10 p.m. |
FDA Funding Priorities * # Generic Drug Science & Research Priorities for FY 2024 (CDER) # Highlighted Research Areas of Interest (CDRH) # Oncology Center of Excellence and BAA Program (OCE) # BAA Overview and Priorities (OCET) # BAA Overview and Priorities (One Health) # BAA Overview and Priorities (Office of Women’s Health)
* Each presentation will be followed by a 5-minute Q&A. |
Dr. Sameer Raney (Q&A Panelist: Ms. Jessie Floura), Dr. Kimberly Maxfield Dr. Michele Lee Dr. Julie Schneider Mr. Robert Orr CAPT Brianna Skinner Dr. Joyce Obidi (Q&A Panelist: Dr. Susan Bersoff-Matcha) |
3:00 p.m. |
Application Process Updates # Application Updates # Overview and Required documents |
Dr. Kinnera Chada, ORSI Mr. Ian Weiss, OAGS |
3:30 p.m. |
Question and Answer Panel # Review of questions submitted via webinar Q&A pod, and in advance to FDABAA@fda.hhs.gov |
Panel Members: ORSI & OAGS |
4:25 p.m. | Adjourn and Closing Remarks |
Note: Recording of the full event (including closed captioning and an audio transcript, presentation slides, and responses to all questions will be posted on the event page.
Acronyms
CDER - Center for Drug Evaluation and Research
CDRH - Center for Devices and Radiological Health
OAGS - Office of Acquisitions and Grants Services
OCE - Oncology Center of Excellence
OCET - Office of Counterterrorism and Emerging Threats
ORSI - Office of Regulatory Science and Innovation
OWH - Office of Women’s Health
Back to the event page